Lodestone Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$425K Sell
354
-9
-2% -$9.2K 0.15% 126
2026
Q1
$334K Buy
363
+21
+6% +$21.3K 0.13% 139
2025
Q4
$367K Sell
342
-26
-7% -$24.9K 0.15% 127
2025
Q3
$281K Buy
368
+53
+17% +$39.4K 0.13% 146
2025
Q2
$245K Sell
315
-54
-15% -$42K 0.12% 149
2025
Q1
$305K Sell
369
-3
-0.8% -$2.5K 0.16% 121
2024
Q4
$287K Sell
372
-53
-12% -$43.9K 0.14% 120
2024
Q3
$376K Sell
425
-56
-12% -$50.3K 0.19% 103
2024
Q2
$436K Sell
481
-17
-3% -$13.6K 0.23% 103
2024
Q1
$387K Sell
498
-63
-11% -$44.8K 0.2% 108
2023
Q4
$327K Buy
561
+63
+13% +$36.8K 0.19% 113
2023
Q3
$267K Sell
498
-3
-0.6% -$1.55K 0.19% 111
2023
Q2
$235K Buy
+501
New +$210K 0.16% 123
2023
Q1
Sell
-550
Closed -$201K 126
2022
Q4
$201K Buy
+550
New +$195K 0.16% 118

Other funds holding LLY

Lodestone Wealth Management's LLY Position: Q2 2026 in Review

Lodestone Wealth Management reduced its Eli Lilly (LLY) stake by 2.5% in Q2 2026, selling an estimated $9.2K and leaving 354 shares worth $425K. The position accounts for 0.15% of the portfolio, ranked #126.

Lodestone Wealth Management first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $436K in Q2 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Lodestone Wealth Management held 354 shares of Eli Lilly worth $425K as of Q2 2026.
  • Lodestone Wealth Management sold 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 0.15% of Lodestone Wealth Management's portfolio in Q2 2026, its #126 holding.
  • Lodestone Wealth Management first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Lodestone Wealth Management's Eli Lilly position peaked at $436K in Q2 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lodestone Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.